Clinical Trial Update: Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing eltrombopag plus rhTPO to eltrombopag alone for immune thrombocytopenia during COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN